4-Hydroxynonenal Promotes Colorectal Cancer Progression Through Regulating Cancer Stem Cell Fate
Antioxidants & Redox Signaling · 01.02.2025 · 42 (4-6) · 265-279
DOI: 10.1089/ars.2023.0530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, erschienen am 01.02.2025. Verfasst von Xu Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nantong Institute of Genetics and Reproductive Medicine, Affiliated Maternity and Child Healthcare Hospital of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Aldehydes, Neoplastic Stem Cells, Colorectal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Aims
Tumor microenvironment (TME) plays a crucial role in sustaining cancer stem cells (CSCs). 4-hydroxynonenal (4-HNE) is abundantly present in the TME of colorectal cancer (CRC). However, the contribution of 4-HNE to CSCs and cancer progression remains unclear. This study aimed to investigate the impact of 4-HNE on the regulation of CSC fate and tumor progression.
Methods
Human CRC cells were exposed to 4-HNE, and CSC signaling was analyzed using quantitative real-time polymerase chain reaction, immunofluorescent staining, fluorescence-activated cell sorting, and bioinformatic analysis. The tumor-promoting role of 4-HNE was confirmed using a xenograft model.
Results
Exposure of CRC cells to 4-HNE activated noncanonical hedgehog (HH) signaling and homologous recombination repair (HRR) pathways in LGR5+ CSCs. Furthermore, blocking HH signaling led to a significant increase in the expression of γH2AX, indicating that 4-HNE induces double-stranded DNA breaks (DSBs) and simultaneously activates HH signaling to protect CSCs from 4-HNE-induced damage via the HRR pathway. In addition, 4-HNE treatment increased the population of LGR5+ CSCs and promoted asymmetric division in these cells, leading to enhanced self-renewal and differentiation. Notably, 4-HNE also promoted xenograft tumor growth and activated CSC signaling in vivo. Innovation and Conclusion: These findings demonstrate that 4-HNE, as a signaling inducer in the TME, activates the noncanonical HH pathway to shield CSCs from oxidative damage, enhances the proliferation and asymmetric division of LGR5+ CSCs, and thereby facilitates tumor growth. These novel insights shed light on the regulation of CSC fate within the oxidative TME, offering potential implications for understanding and targeting CSCs for CRC therapy. Antioxid. Redox Signal. 42, 265-279.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nantong Institute of Genetics and Reproductive Medicine, Affiliated Maternity and Child Healthcare Hospital of Nantong University, Nantong, China.
- Nantong Key Laboratory of Genetics and Reproductive Medicine, Nantong, China.
- Department of Internal Medicine, Gastroenterology Section, Affiliated Maternity and Child Healthcare Hospital of Nantong University, Nantong, China.
- Department of Clinical Laboratory, Affiliated Nantong Hospital of Shanghai University and the Sixth People's Hospital of Nantong, Nantong, China.
- Department of Clinical Laboratory, Affiliated Maternity and Child Healthcare Hospital of Nantong University, Nantong, China.
ORCID-Profile: Xingmin Wang
Zitieren
APA
Huang, X., Huang, L., Ma, C., Hong, M., Xu, L., Ju, Y., Li, H., Wang, Y., & Wang, X. (2025). 4-Hydroxynonenal Promotes Colorectal Cancer Progression Through Regulating Cancer Stem Cell Fate. Antioxidants & Redox Signaling, 42(4-6), 265-279. https://doi.org/10.1089/ars.2023.0530
Vancouver
Huang X, Huang L, Ma C, Hong M, Xu L, Ju Y, et al. 4-Hydroxynonenal Promotes Colorectal Cancer Progression Through Regulating Cancer Stem Cell Fate. Antioxidants & Redox Signaling. 2025;42(4-6):265-279. doi:10.1089/ars.2023.0530
BibTeX
@article{Huang2025,
author = {Huang, Xu and Huang, Lin and Ma, Chunhua and Hong, Mingyang and Xu, Lili and Ju, Yuanyuan and Li, Haibo and Wang, Yilang and Wang, Xingmin},
title = {4-Hydroxynonenal Promotes Colorectal Cancer Progression Through Regulating Cancer Stem Cell Fate},
journal = {Antioxidants & Redox Signaling},
year = {2025},
volume = {42},
number = {4-6},
pages = {265--279},
doi = {10.1089/ars.2023.0530}
}
EUVIMED